Fasoracetam
Appearance
| |||
Names | |||
---|---|---|---|
IUPAC name
(5R)-5-(piperidine-1-carbonyl) pyrrolidin-2-one
| |||
Identifiers | |||
3D model (JSmol)
|
|||
ChEMBL | |||
ChemSpider | |||
KEGG | |||
PubChem CID
|
|||
CompTox Dashboard (EPA)
|
|||
| |||
| |||
Properties | |||
C10H16N2O2 | |||
Molar mass | 196.246 g/mol | ||
Pharmacology | |||
Oral | |||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Fasoracetam (NS-105, 5-oxo-D-prolinepiperidinamide monohydrate) is a research chemical studied for its potential as a nootropic class drug of the racetam family.[1]
Effects
Fasoracetam appears to act as a GABAB receptor antagonist. It has been shown to block memory disruptions caused by Baclofen, a GABA B agonist.[2] Fasoracetam upregulates GABA B receptors after repeat dosing.[3]
Fasoracetam may act as a mGluR agonist and research into the efficacy for treating ADHD and cognitive impairment is currently being conducted.[4] [5]
Similar to Coluracetam, Fasoracetam enhances high affinity choline reuptake (HACU). [2]
References
- ^ "5-oxo-D-prolinepiperidinamide monohydrate - Compound Summary". Retrieved 21 July 2013.
- ^ a b "Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer".
- ^ "Effect of a novel cognition enhancer NS-105 on learned helplessness in rats: possible involvement of GABA(B) receptor up-regulation after repeated treatment".
- ^ "A novel cognition enhancer NS-105 modulates adenylate cyclase activity through metabotropic glutamate receptors in primary neuronal culture".
- ^ http://www.research.chop.edu/forms/btob/Oct12BtoB.pdf